Skip to content
healthcare.dev
Get a free key

Cevimeline Hydrochloride

NDC 16571-657, Cevimeline Hydrochloride, capsule, from Rising Pharma Holdings, Inc..

Product NDC
16571-657
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203775
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16571-657 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CEVIMELINE HYDROCHLORIDE30 mg/1

Pharmacologic classes

Cholinergic Muscarinic Agonists [MoA]; Cholinergic Receptor Agonist [EPC]

Package NDCNDC-11Package
16571-657-1016571065710100 CAPSULE in 1 BOTTLE (16571-657-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d4bd942a-1339-40c5-8fd4-850da5a69635

  • NADAC price for package 16571065710

    GET /v1/drugs/nadac/16571065710

Use it

Look up 16571-657 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16571-657 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16571-657. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.